skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-four new guidance documents were posted to the tracker since its last update.

 

 

 

 

 

Forty-four new guidance documents on medical devices and diagnostics issued by regulatory authorities from around the world were added to Medtech Insight's Guidance Tracker in the last two months (from Oct. 12 to Nov. 30).

 

 

The US FDA issued 12 guidelines since the last update, including a final document explaining when to submit a 510(k) for a software change to an existing device. While the guideline is helpful, an industry expert believes it does not do enough to address the bigger issue of allowing FDA more discretion to let software medical device-makers update their products quickly without burdensome agency oversight. (Also see "Despite 510(k) Software Guidance, US FDA's Hands May Still Be Tied" - Medtech Insight, 17 Nov, 2017.)

 

 

The updated list also includes a draft guideline from the Saudi Food and Drug Authority outlining the procedure that local manufacturers and authorized representatives should follow to address field safety notices (FSNs) issued in relation to their devices.

 

 

The updated list of new guidance documents is below. The full Medtech Guidance Tracker is online.

 

 

Medtech Guidance Tracker: October-November 2017

 

Key:

WHO: World Health Organization

HC: Health Canada

EMA: European Medicines Agency

NBOG: Notified Body Operations Group

HPRA: Health Products Regulatory Authority

MDA: Medical Device Authority

FDA Philippines: Food and Drug Administration Philippines

Saudi FDA: Saudi Food & Drug Authority

HSA: Health Sciences Authority

MCC: Medicines Control Council

Swissmedic: Swiss Agency for Therapeutic Products

MHRA: Medicines and Healthcare products Regulatory Agency

FDA: Food and Drug Administration

Read also

;

Next steps

各製品の無料トライアルまたは担当スタッフによるデモンストレーションを常時受け付けています。お気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡ください。

  • 日本:         +81 3 6273 4260
  • 米国 (無料):+1 888 670 8900
  • 米国 (有料):+1 908 547 2200
  • 英国&欧州:+44 (20) 337 73737
  • 豪:      +61 2 8705 6907

お問合せフォームまたはEメールでもご質問を承っています(日本オフィス営業時間:平日9時~18時)

 

オンラインショップのレポートストアでは、常時1000以上の市場分析レポートをご提供しています。

お探しの情報が見つからない場合は、左記のお問い合わせ先までお気軽にご連絡ください。